194 related articles for article (PubMed ID: 24246350)
1. Tablet levothyroxine (L-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to L-T4 in soft gel capsule.
Vita R; Benvenga S
Endocr Pract; 2014 Mar; 20(3):e38-41. PubMed ID: 24246350
[TBL] [Abstract][Full Text] [Related]
2. A novel formulation of L-thyroxine (L-T4) reduces the problem of L-T4 malabsorption by coffee observed with traditional tablet formulations.
Vita R; Saraceno G; Trimarchi F; Benvenga S
Endocrine; 2013 Feb; 43(1):154-60. PubMed ID: 22932947
[TBL] [Abstract][Full Text] [Related]
3. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
4. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors.
Vita R; Saraceno G; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4481-6. PubMed ID: 25259910
[TBL] [Abstract][Full Text] [Related]
5. Advancements in the treatment of hypothyroidism with L-T4 liquid formulation or soft gel capsule: an update.
Fallahi P; Ferrari SM; Ruffilli I; Ragusa F; Biricotti M; Materazzi G; Miccoli P; Antonelli A
Expert Opin Drug Deliv; 2017 May; 14(5):647-655. PubMed ID: 27552635
[TBL] [Abstract][Full Text] [Related]
6. The administration of L-thyroxine as soft gel capsule or liquid solution.
Vita R; Fallahi P; Antonelli A; Benvenga S
Expert Opin Drug Deliv; 2014 Jul; 11(7):1103-11. PubMed ID: 24896369
[TBL] [Abstract][Full Text] [Related]
7. Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients.
Benvenga S
J Clin Transl Endocrinol; 2019 Dec; 18():100204. PubMed ID: 31844631
[TBL] [Abstract][Full Text] [Related]
8. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
9. Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
Jojima T; Shinzawa T; Ohira E; Sakurai S; Tomaru T; Iijima T; Kogai T; Usui I; Aso Y
Endocr J; 2022 Aug; 69(8):941-945. PubMed ID: 35249899
[TBL] [Abstract][Full Text] [Related]
10. Levothyroxine Sodium Oral Solution Normalizes Thyroid Function in a Patient with Hashimoto's Disease, Gastritis, Diabetic Gastroparesis, and Small Intestinal Bacterial Overgrowth (SIBO).
Bohinc Henderson B
Int Med Case Rep J; 2021; 14():627-632. PubMed ID: 34557042
[TBL] [Abstract][Full Text] [Related]
11. Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption.
Trimboli P; Virili C; Centanni M; Giovanella L
Front Endocrinol (Lausanne); 2018; 9():118. PubMed ID: 29619010
[TBL] [Abstract][Full Text] [Related]
12. In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
Morini E; Catalano A; Lasco A; Morabito N; Benvenga S
Endocrine; 2019 Sep; 65(3):569-579. PubMed ID: 30919287
[TBL] [Abstract][Full Text] [Related]
13. Effect of morning versus night-time administration of proton pump inhibitor (pantoprazole) on thyroid function test in levothyroxine-treated primary hypothyroidism: a prospective cross-over study.
Awasthi A; Chakraborty PP; Agrawal N; Sinha A; Pandey AK; Maiti A
Thyroid Res; 2023 Jun; 16(1):15. PubMed ID: 37259094
[TBL] [Abstract][Full Text] [Related]
14. Increased Requirement of Replacement Doses of Levothyroxine Caused by Liver Cirrhosis.
Benvenga S; Capodicasa G; Perelli S; Ferrari SM; Fallahi P; Antonelli A
Front Endocrinol (Lausanne); 2018; 9():150. PubMed ID: 29720960
[TBL] [Abstract][Full Text] [Related]
15. L-T4 Therapy in Enteric Malabsorptive Disorders.
Fallahi P; Ferrari SM; Elia G; Ragusa F; Paparo SR; Antonelli A
Front Endocrinol (Lausanne); 2021; 12():626371. PubMed ID: 33708175
[TBL] [Abstract][Full Text] [Related]
16. Thyroid Hormone Profile in Patients Ingesting Soft Gel Capsule or Liquid Levothyroxine Formulations with Breakfast.
Cappelli C; Pirola I; Gandossi E; Cristiano A; Daffini L; Agosti B; Casella C; Castellano M
Int J Endocrinol; 2016; 2016():9043450. PubMed ID: 27313613
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Clinical Implications of Two Non-Tablet Oral Formulations of L-Thyroxine in Patients with Hypothyroidism.
Trimboli P; Mouly S
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743549
[TBL] [Abstract][Full Text] [Related]
18. Thyroid blood flow in inferior thyroid artery as predictor for increase in levothyroxine dosage during pregnancy in women with Hashimoto's thyroiditis - a retrospective study.
Kurajoh M; Yamasaki A; Nagasaki T; Nagata Y; Yamada S; Imanishi Y; Emoto M; Takahashi K; Yamamoto K; Shintani A; Inaba M
BMC Pregnancy Childbirth; 2019 Jul; 19(1):232. PubMed ID: 31277608
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine in Autoimmune Thyroiditis and Hypothyroidism.
Ferrari SM; Ragusa F; Elia G; Paparo SR; Mazzi V; Baldini E; Benvenga S; Antonelli A; Fallahi P
Front Pharmacol; 2021; 12():750380. PubMed ID: 34867359
[TBL] [Abstract][Full Text] [Related]
20. Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.
Benvenga S; Di Bari F; Vita R
Endocrine; 2017 Apr; 56(1):138-145. PubMed ID: 28155174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
